Literature DB >> 28361975

Heart failure: No early benefits of adjunct therapy with tolvaptan for acute heart failure.

Irene Fernández-Ruiz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28361975     DOI： 10.1038/nrcardio.2017.46

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.

Authors:  Marvin A Konstam; Michael Kiernan; Arthur Chandler; Ravi Dhingra; Freny Vaghaiwalla Mody; Howard Eisen; W Herbert Haught; Lynne Wagoner; Divya Gupta; Richard Patten; Paul Gordon; Kenneth Korr; Russell Fileccia; Susan J Pressler; Douglas Gregory; Patricia Wedge; Douglas Dowling; Matthew Romeling; Jeremy M Konstam; Joseph M Massaro; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2017-03-21       Impact factor: 24.094

2.  Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.

Authors:  G Michael Felker; Robert J Mentz; Robert T Cole; Kirkwood F Adams; Gregory F Egnaczyk; Mona Fiuzat; Chetan B Patel; Melvin Echols; Michel G Khouri; James M Tauras; Divya Gupta; Pamela Monds; Rhonda Roberts; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2016-09-18       Impact factor: 24.094
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.